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Removal of digoxin and doxorubicin by multidrug resistance [1, 2]. The hollow fiber module was used for cell culture
protein-overexpressed cell culture in hollow fiber. since the 1970s [3]. This system was applied to experi-
Background. Drug removal by hemoperfusion is not effec- mental hepatic failure by Olumide et al and to patients
tive because of its lower capacity and nonspecificity. We in-
by Matsumura et al [4, 5]. Such a hybrid type of artificialvented a new hybrid type of hemodialysis system.
organ is also applicable in principle to the artificial kid-Methods. An immortalized proximal tubular cell line (PCTL)
overexpressing human multidrug resistance protein-1 (MDR-1) ney. Because the proximal tubule plays a major part in
was cultured either on polus filter membranes or on hollow the elimination of drugs in the kidney [6], application
fiber modules. The modules were incubated in an incubator of the proximal tubular cell culture to the hollow fiber
conditioned with 95% O2/5% CO2 that was kept at 378C. At modules is expected to provide an efficient tool that10 days on culture, the drug-transporting capacity of these
affords active elimination of drugs from circulatingsystems was examined.
blood. In an attempt to treat patients with acute renalResults. MDR was successfully expressed in the PCTL as
evaluated by Western blot. Basolateral to apical transport of failure, some groups have used native cell lines for a
3H-digoxin, a substrate of MDR, was examined by using the culture system (abstract; Nikolovlsky J et al, J Am Soc
cells cultured on a microporous membrane. PCTL-MDR Nephrol 7:1376, 1996) [7].
showed a 10-fold increase in MDR protein and a 12-fold in-
Recent advances in cellular and molecular biology willcrease of 3H-digoxin transport through a cell layer on a micro-
make it possible to construct more efficient systems forporous membrane. The increase of the transport was abolished
the hybrid artificial kidney. It is now possible to isolateby the addition of 5 mm verapamil, an inhibitor of MDR, to
the apical side. When digoxin or doxorubicin was infused in and clone distinct renal proximal tubules and obtain
the capillary side of the hollow fiber modules after 10 days on more stable cell lines by immortalizing them [8]. Several
culture, the largest portion of the drugs was transported to the types of transporters have recent clones that are respon-pericapillary side (P , 0.001). This transport was also abolished
sible for drug elimination from the kidney, includingby an addition of verapamil to the pericapillary side. Transport
organic anion transporters [9], organic cation transport-of para-aminohippurate was not different between two cells,
and inulin was not transported in this system. ers [10], and multidrug resistance protein (MDR) [11,
Conclusion. The hybrid hollow fiber system can selectively 12]. The application of immortalized cells, which overex-
remove a significant amount of drugs that have an affinity to press these transporter molecules, to the hollow fiber
MDR from the medium, and perfuse them to the capillary side
modules is expected to provide an efficient hybrid ma-in vitro.
chine that can actively eliminate specific drugs from cir-
culation.
We have succeeded in constructing a hybrid artificialAlthough many anticancer drugs are used for the treat-
kidney using overexpressed MDR, which allows thement of neoplasm, cancer therapy is sometimes limited
elimination of drugs specific to this transporter. In thisbecause of adverse reactions to drugs. In case of drug
study, we report an in vitro study showing that digoxinintoxication, hemoperfusion can be used for the purpose
and doxorubicin, which are known to be specificallyof drug elimination, but this maneuver is not effective
transported by MDR, are selectively and efficiently re-
moved by this module.
Key words: artificial kidney, proximal tubule, MDR, digoxin, doxorubi-
cin, hemodialysis.
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in this study [8]. Briefly, rabbit proximal tubule cells and doxorubicin was measured by sampling of 20 ml
were obtained by microdissection of renal cortical slices apical medium at one, two, and three hours after chang-
under a stereomicroscope and were cultured in culture ing the medium. 14C-inulin (600 nm; NEM) was also
medium (DMEM/Ham’s F-12, 25 mm NaHCO3, with low added simultaneously to the basolateral side to deter-
glucose plus 4 mg/dl neomycin). After the cells reached mine whether there was a paracellular leak. In some
confluence, they were transformed with plasmid pSVneo3 wells, 5 mm verapamil, which is an inhibitor of MDR,
(ATCC, Rockville, MD, USA), which possessed SV40 was added to the apical side. To estimate maximum
large T antigen (early region promoter) and G418 resis- transport capacity of the cells on microporous filter, we
tance gene by lipofection. G418 resistance cells were added radiolabeled drugs with radiounlabeled drugs in
selected and used as a cell line. some experiments. The apical to basolateral transport
Next, plasmid pHIRMDR1, containing human mdr-1 of digoxin was also determined in other dish. Radioactiv-
gene [13], was introduced to the PCTL by electropora- ity of 14C and 3H was counted by a liquid scintillation
tion (Cell-Porator; BRL Life Technology Inc., Rockville, counter (LSC-3500; Aloka, Tokyo, Japan).
MD, USA) and was incubated with the culture medium
(DMEM/Ham’s F-12, 25 mm NaHCO3 with low glucose Cell culture in hollow fiber module
plus 40 mg/ml neomycin) without serum for 48 hours. The hollow fiber module system for immunoisolation
Thereafter, the medium was changed to that which con- (Culture floe; Asahi Medical Co. Ltd., Tokyo, Japan)
tained an additional 10% fetal calf serum (FCS) and 600 was constructed according to the manufacturer’s instruc-
mg/ml colchicine. Surviving cells, named PCTL-MDR, tions [15, 16] with slight modifications (Fig. 1). Fibers
were subcultured in identical medium and were used in are made of polyethylene, and the inner diameter of
the following experiments. Usually, PCTL-MDR reached each fiber is 350 mm, and its surface is 200 cm2. The total
confluency in 10 to 14 days when seeded at 1 3 105 cells volume in the lumen of the hollow fibers is 2 ml, and
in a 100 3 20 mm dish. Only passages 4 to 10 were used the total extra-fiber volume in the chamber is also 2 ml.
for these experiments. After setting up the system, 5 ml of 0.02% acid soluble
type I collagen (Sigma, St. Louis, MO, USA) were per-Western blot analysis of cell membrane
fused to the pericapillary side, and the medium (DMEM/
To confirm whether MDR-1 protein was successfully Ham’s F-12, 10% FCS with neomycin) was circulated
expressed, we performed Western blot analysis [14]. into the capillary side for 48 hours at 5% CO2/95% O2PCTL-MDR and PCTL were disrupted in isotonic buffer at 378C atmosphere in order to search for bacterial con-
by nitrogen cavitation, and a membrane vesicle was ob-
tamination (Fig. 1). Next, 1 3 108 cells were injected
tained by sucrose gradient centrifugation. Twenty micro-
to the pericapillary side after temporal termination ofgrams of vesicles were resolved by sodium dodecyl sul-
circulation for 30 minutes. The medium was perfusedfate-polyacrylamide gel electrophoresis (SDS-PAGE)
again to the capillary side at a very slow rate (usuallyon 7% gels, were electroblotted onto nitrocellulose, and
less than 1 ml/hr) by a peristaltic pump for 60 minutes.were reacted with anti–P-glycoprotein monoclonal anti-
Then the chamber was rotated 908 along capillary axis,body C219. The chemiluminescence method was em-
and the same number of cells was injected to the pericapi-ployed for signal detection, and densitometric analysis
llary side and it was left for 30 minutes. We repeatedwas performed. The relative difference of intensity be-
these procedures four times to achieve the cell growthtween PCTL-MDR and PCTL was calculated after the
on the entire surface of the fibers. Thereafter, the infu-same amount of protein was applied to the gel.
sion rate into the capillary lumen was gradually increased
to approximately 1 ml/min, which was maintained for 10Measurement of transport of 3H-digoxin and
days. Our preliminary data showed that when the flowdoxorubicin across a cell layer cultured on a
rate increased up to 5 ml/min, the inulin transport (men-membrane filter
tioned later in this article) increased to more than 1 ml/The cells were seeded onto microporous polycarbo-
min (data not shown). No broken cells or cell debrisnate membrane filter (3.0 mm pore size, Transwellt 3414;
was found in the out-flow fluid. It is thus unlikely thatCorning Costar, Acton, MA, USA) at a cell density of
detachment of the cells caused this phenomenon. The1 3 106 cells/cm2. They were cultured with 2.6 ml of me-
rise of hydraulic pressure associated with the infusiondium (DMEM/Ham’s F-12, 10% FCS plus neomycin)
rate may increase inulin transport. Furthermore, para-in the basolateral side and 1.6 ml in the apical side at
aminohippurate (PAH) transport (discussed later in thisconditions of 378C and 5% CO2/95% O2 for six days
article) was gradually decreased when cells were cultured[14]. On the day of the experiments, the medium in the
under the same condition for more than 10 days, indicat-basolateral side was changed to that containing 100 nm
ing that cell viability was maximum on day 10 in this3H-digoxin or 10 mm 3H-doxorubicin (NEM, Boston, MA,
USA). The basolateral to apical transport of 3H-digoxin system (data not shown).
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Fig. 1. Schematic illustration of the culture
system and the measurement of drug trans-
port. The system was constructed in a clean
bench, and the medium was circulated in an
incubator conditioned with 95% O2/5% CO2
at 378C for 48 hours before an injection of cell
to check bacterial contamination. The trans-
port study was performed before and 10 days
after culturing cells. The pericapillary side was
infused with the incubation medium by a sy-
ringe pump only during the transport study.
Measurement of drug transport by proximal tubular on the drug transport of 5 mm verapamil added to the
pericapillary side. The transport rate usually reachedcell line-multidrug resistance protein at hollow
fiber module a stable level within 60 minutes after the initiation of
perfusion. The mean of four measurements of this pa-Fetal calf serum-free medium with approximately 5
rameter per 30 minutes (from 1 to 3 hours) was consid-ng/ml digoxin (Wako Pure Chemical, Osaka, Japan) or
ered to be the transport rate. The flux was determined6 mg/dl doxorubicin (a gift from Kyowa Hakko Co. Ltd.,
just before the injection of cells and 10 days after theTokyo, Japan) plus 2 mg/dl PAH, and 10 mg/dl inulin
cell culture on hollow fiber. Another set of transportwas infused to the capillary side by a syringe pump at a
studies for doxorubicin were performed using 10% FCSflow rate of 1 ml/min after stopping of peristaltic pump.
and digoxin for 10% bovine serum albumin, becauseThe fluid was collected at the opposite side of the cham-
protein binding with these drugs may affect their trans-ber every 30 minutes for 3 hours (Fig. 1). The medium
port rates.without drugs was perfused to the pericapillary side at
The digoxin concentration was measured by a mono-the same rate in a simultaneous countercurrent manner,
clonal antibody fluorescence polarization immunoassayand the fluid was also collected. We measured the volume
technique (TDx autoanalyzer; Dinabot Co. Ltd., Tokyo,and drug concentration of the collected fluid, and calcu-
Japan) [17], and the doxorubicin concentration was de-lated the flux of the drugs that appeared on the pericapil-
termined by high-performance liquid chromatographylary side (Qc→p) and those that disappeared from capillary
[18]. Determinations of inulin and PAH concentrationside (Q9c→p) using the following equation:
were followed to Fjeldbo and Stamey [19] and Brun et
Qc→p 5 Vp9 · Cp9 al [20], respectively.
Q9c→p 5 VO9 · Co9 2 Vo · Co
Chemicalswhere Vp9 and Cp9 were the flow rate and drug concentra-
DMEM/Ham’s F-12 was purchased from GIBCOtion of the medium that was derived from the pericapil-
(Grand Island, NY, USA), and doxorubicin was gener-lary side. Vo and Co were those of medium which entered
ous gift from Kyowa Hakko Co. Ltd. (Tokyo, Japan).into capillary lumen, and Vo9 and Co9 were those of me-
Other reagent grade chemicals were purchased fromdium derived from capillary lumen. Because the differ-
Sigma.ences between Qc→p and Q9c→p were less than 0.2% in all
experiments, only the results concerning Qc→p are shown.
StatisticsThe pericapillary to the capillary side transport drug flow
Statistical analysis was done by analysis of variance(Qp→c) was also measured by monitoring the volume and
(ANOVA) and paired t-test as appropriate. All resultsconcentration of the drugs that entered into the hollow
were expressed as mean 6 se. P values of less than 0.05fiber and came out from the fiber in the same manner.
In some experiments, we also examined the effect were regarded as significant.
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RESULTS
Establishment of proximal tubule cells overexpressing
human multidrug resistance protein-1
We introduced pHIRMDR1 to the PCTL by electro-
poration and could obtain a clone that was resistant to
600 mg/ml colchicine. Figure 2 shows Western blots of
the membrane fraction of this cell line, named PCTL-
MDR. The molecular size of MDR-1 was 185 kDa. In
Figure 2B, the ordinate represents relative intensity with
same amount of total membrane protein from PCTL.
This cell line showed 11 6 1.2 (N 5 5) times higher
expression of this protein than PCTL (P , 0.001), a
finding in good agreement with an earlier report that
introduced human MDR-1 to LLC-PK1 cells [14], al-
though our clone is more resistant to a higher concentra-
tion of colchicine.
Next, we examined the function of the cells by measur-
ing basolateral to apical membrane transport of 3H-digoxin.
As shown in Figure 3A, the rate of 3H-digoxin transport
was 12.5 6 2.1-fold (N 5 4) higher in PCTL-MDR than
in PCTL (P , 0.001). 14C-inulin transport was negligible
(less than 0.1%) in both types of cells. The transport
in PCTL-MDR was abolished by the addition of 5 mm
verapamil to the apical side. These findings were also
compatible with a previous study that introduced human
MDR-1 to LLC-PK1 cells [14], although our clone seems
to have a higher transport rate. We also examined the
apical to basolateral transport of 3H-digoxin. As shown
in Figure 3A, the transport was far smaller than that of
basolateral to apical transport, and it was not changed
by the addition of the same concentration of verapamil
to bath. Basolateral to apical transport of 3H-doxorubicin
increased in PCTL-MDR than PCTL (P , 0.001), as
well as transport of digoxin (Fig. 3B). These results indi-
cated that PCTL-MDR possesses more than a tenfold
higher capacity to extrude substrates for MDR, and the
MDR protein was expressed mainly in the apical side of
the cell. The Km and Vmax for digoxin and doxorubicin
were approximately 100-fold higher in PCTL-MDR than
Fig. 2. Representative (A) and summary of relative expression (B) of
PCTL (in PCTL-MDR they were 960 6 10.5 ng/ml and P-glycoprotein by Western blot analysis in membrane fraction of PCTL-
MDR cells. Twenty micrograms of membrane fraction of PCTL and969.8 6 8.9 pmol/mg 1 protein for digoxin, and 755 6
PCTL-MDR cells were applied to gel. The molecular size of MDR-113 mg/ml, 803 6 8.9 nmol/mg · protein for doxorubicin,
protein was 185 kDa. Data are expressed as mean 6 se. *P , 0.001 vs.
respectively; N 5 4; in PCTL they were 10.1 6 1.3 ng/ml, PCTL.
7.9 6 0.9 pmol/mg · protein for digoxin and 76 6 7 mg/ml,
92 6 10 nmol/mg · protein for doxorubicin, respectively
(N 5 4; Fig. 4).
considerable amount of digoxin dose dependently by this
Culture of PCTL-MDR in the hollow fiber module system, whereas PCTL did not. Thirty to 60 minutes
after the initiation of infusion, the transport rate becameThe immortalized proximal tubule cell line PCTL-
MDR was cultured onto the pericapillary side of colla- stable. The mean transport rate of digoxin was 115 6
25 ng/30 min in PCTL-MDR, whereas that of PCTL wasgen-treated hollow fiber module for 10 days and trans-
port of the drugs, inulin, and PAH measured from the 18 6 10 ng/30 min during infusion of 4.05 ng/ml of digoxin
(P , 0.001). The transport was reduced to less than 10%capillary to pericapillary sides simultaneously. As shown
in Figure 5A, PCTL-MDR allowed the transport of a by the addition of 5 mm verapamil to the pericapillary
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Fig. 3. Transport of 3H-digoxin (A) and 3H-doxorubicin (B) across the
cellular layer cultured over microporous membranes. 14C-inulin was
added simultaneously, and its transport was less than 0.1% during three
hours (data not shown). An open circle and rectangle denote basolateral
to apical (B–A) and apical to basolateral (A–B) transport, respectively.
The closed circle is an effect of verapamil to the apical side on B–A,
and the closed rectangle is an effect of basolateral verapamil on A–B.
The open triangle is PCTL. Data are expressed as mean 6 se (N 5 3).
*P , 0.001 vs. PCTL.
side. The pericapillary to capillary side of the transport Finally, we examined the effect of protein on drug
of digoxin in PCTL-MDR was 20 6 12 ng/30 min when transport. Although the basal transport rate was slightly
4.05 ng/ml of digoxin was infused (Fig. 5A). Inulin trans- but significantly reduced by using a medium-containing
port was negligible in both types of cells without any protein (P , 0.01), a considerable amount of the drugs
change by verapamil. Pericapillary to capillary side trans- was still removed through the system (Fig. 7).
port of inulin was also similar (Fig. 5B). PAH transports
of PCTL-MDR (450 6 50 ng/30 min) and PCTL (415 6
DISCUSSION55 ng/30 min) did not differ significantly. In addition,
In the case of drug intoxication, hemoperfusion is usedthey were not affected by verapamil (data not shown).
for the purpose of drug removal, but this maneuver isSimilar results were obtained for doxorubicin trans-
not effective for the following reasons [1, 2]. First, theport. As shown in Figure 6A, doxorubicin was removed
efficacy of drug removal is not as high as expected. Sec-from the capillary lumen with the rate of 108 6 12 mg/
ond, the system removes not only drugs but also function-30 min in PCTL-MDR, which was 12 times higher than
ally important materials, such as proteins and platelets.in PCTL (P , 0.001). The transport rate increased pro-
Recent advances in cellular and molecular biology haveportionally when the concentration of the drug was in-
made it possible to construct a more efficient hybridcreased at least 20 mg/ml. The pericapillary addition of
artificial kidney.5 mm verapamil almost completely abolished transcapil-
In this study, we invented a unique hybrid artificiallary transport of the drug, while it did not affect inulin
kidney having a high capacity to transport specific sub-transport (Fig. 6). The pericapillary to capillary side
strates for MDR. Several drugs such as digoxin and doxo-transport of doxorubicin was smaller than that of capil-
rubicin are transported via MDR in the apical membranelary to pericapillary transport, thereby supporting the
of renal tubular cells [11, 14]. The cDNA of the genefinding that MDR protein expresses at the apical side of
PCTL-MDR. was cloned and found to belong to the ATP-binding
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Fig. 4. Transport kinetics of digoxin and dox-
orubicin in PCTL-MDR (h) and PCTL (s).
The Km and Vmax of the two drugs were approx-
imately 100 times higher in PCTL-MDR than
PCTL.
cassette superfamily [21]. As shown in these results, this 0.05 ml/min at a perfusion rate of approximately 1 ml/
min, whereas the renal clearance of these drugs in hu-system can selectively remove a considerable amount of
the drugs having affinity for MDR, at least under an in mans is approximately 100 and 50 ml/min, respectively
[22, 23]. Therefore, to apply this system to humans, thevitro condition. Clearance of digoxin and doxorubicin
by this system was calculated as 0.90 6 0.05 and 0.69 6 module must be scaled up by 100-fold. Because the vol-
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Fig. 4. Continued.
ume of the intracapillary and pericapillary spaces was inulin in the absence of a cultured cell layer, it became
tight enough to prevent transport of inulin in 10 daysapproximately 2 ml and because the surface area of fiber
was 200 cm2, it may not be difficult to scale up the module when cultured cells were supposed to be confluent.
The most important issue of our study is that we ap-by 100-fold.
Although the hollow fiber module is permeable to plied immortalized proximal tubule cells expressing an
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Fig. 5. Transport of digoxin (Jdig; A) and inulin (Jinulin; B) before and 10 days after cell culture in the hollow fiber system. The mark represents
pericapillary to capillary transport of the drugs in addition of verapamil to the capillary side transport (N 5 4), whereas the others show the
capillary to pericapillary side transport in addition of verapamil to the pericapillary side transport. Data are expressed as mean 6 se. Symbols
are: (s) digoxin 7.25 ng/ml, N 5 4; (h) 5.85 ng/ml, N 5 5; (n) 4.05 ng/ml, N 5 6; (m) 4.05 ng/ml, N 5 5 [MDR(2)]; (X) 4.05 ng/ml, N 5 4
(pericapillary to capillary); *P , 0.001 vs. basal; **P , 0.001 vs. before verapamil on day 10.
Fig. 6. Transport of doxorubicin (JDOX; A) and inulin (B) before and 10 days after cell culture in the hollow fiber system. The mark represents
the pericapillary to capillary transport of the drugs in addition of verapamil to the capillary side (N 5 4), whereas the others demonstrate the
capillary to pericapillary side transport in addition of verapamil to pericapillary side. Data are expressed as mean 6 se. Symbols are: (s) DOX
20 mg/ml, N 5 5; (h) DOX 12 mg/ml, N 5 5; (n) DOX 6 mg/ml, N 5 5; (m) DOX 6 mg/ml [MDR(2)], N 5 4; (X) DOX 6 mg/ml, N 5 4
(pericapillary to capillary); *P , 0.001 vs. basal; **P , 0.001 vs. before verapamil on day 10.
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Fig. 7. Effects of protein binding on the drug transport. The transport of doxorubicin in the medium containing 10% FCS (A) and digoxin in
medium containing 10% bovine serum albumin (B) before and 10 days after cell culture in the hollow fiber system is shown. Data are expressed
as mean 6 se. Symbols in A are: (n) DOX 6 mg/ml, N 5 5; (m) DOX 6 mg/ml [MDR(2)], N 5 4. Symbols in B are: (s) DOX 7.25 ng/ml, N 5 3;
(n) DOX 4.05 ng/ml, N 5 4; *P , 0.001 vs. basal; **P , 0.001 vs. before verapamil on day 10.
extrinsic gene in this hollow fiber system. If we obtain ported for the substrate of MDR as well as doxorubicin,
such as daunomycin, vinblastin, actinomycin D, cyclo-gene-introduced cells that possess certain physiological
and pharmacological functions, we might be able to cul- sporine A, and tacrolimus. Possibly our system may be
applicable for the treatment of intoxication of theseture these cells in this system and provide functions to
patients. Thus, this approach may be useful not only for drugs, too.
Most drugs bind to protein in the body, and only thethe treatment of drug intoxication but for the compensa-
tion of physiological functions. unbound fraction of drugs is transported by renal cells
in vivo. The ratios of bound fraction of digoxin andAnother unique feature of this system resides in its
specificity for transporting substances: The machine re- doxorubicin are 27 and 71%, respectively [25]. In order
to determine the influence of protein binding to drugsmoves only substrates of the transporter. Such a selective
removal of certain substances is not expected in hemo- in this system, we examined the effect of proteins to the
transport. As shown in Figures 4A, 5A, and 6, althoughperfusion, which is now used in clinical situations. PAH
is known to be transported via organic anion transporter the drug transport decreased by approximately 25% in
doxorubicin and 11% in digoxin, a considerable amountin the proximal tubule that is distinct from MDR. The
observation that the PAH transport rate was not differ- of the drug was still removed from the capillary side.
Based on these findings, we think that bound drug disso-ent between PCTL-MDR and PCTL confirmed the high
specificity of the system. ciates from the protein during the elimination of un-
bound drug from the perfusate. Thus, we believe thatWe did not examine whether the MDR-1 protein re-
ally existed in the apical membrane of PCTL-MDR. our system is useful for the removal of drugs even if
their protein-binding ratios are high.However, other groups reported that MDR-1 was sorted
to the apical side of porcine kidney cells when they intro- Our results showed that the transport capacity for two
drugs in PCTL-MDR was approximately 100-fold higherduced the human MDR-1 gene [14, 24]. Our results are
compatible with the idea that functional MDR is more than PCTL. For doxorubicin, the Km of PCTL-MDR was
higher than in cancer cells, which naturally express MDRabundant in the apical membrane of PCTL-MDR. The
smaller transport rate of digoxin and doxorubicin from [26]. Km for the two drugs in PCTL was comparable with
that of LLC-PK1 [27, 28].the apical to basolateral side and the ineffectiveness of
basolateral verapamil to the transport also support our In summary, we constructed a new hybrid artificial
kidney for drug removal by culturing renal cells with theconclusion. In addition, the amount of MDR protein
might be larger than that shown by Tanigawara et al, extrinsic gene (human MDR-1) and examined its efficacy
in vitro. A large amount of substrates of MDR (digoxinbecause our cells were resistant to a higher concentration
of colchicine, another substrate of MDR [14]. Several and doxorubicin) was transported from the capillary to
pericapillary side by this system. In the presence of pro-anticancer drugs and immunosuppressants were re-
Tsuruoka et al: Hybrid kidney for drug removal 163
AV, Willingham MC: A retrovirus carrying an MDR1 cDNAtein in the medium, a considerable amount of the drug
confers multidrug resistance and polarized expression of P-glyco-
was still removed by this system in vitro. This system protein in MDCK cells. Proc Natl Acad Sci USA 85:4486–4490,
1988might be viable for various situations with the introduc-
12. Ueda K, Cornwell MM, Gottesman MM, Pastan I, Roninsontion of other extrinsic genes. Further in vivo studies are
IB, Ling V, Riordan JR: The mdr1 gene, responsible for multidrug-
needed to ascertain the merits of this system. resistance, codes for P-glycoprotein. Biochem Biophys Res Com-
mun 141:956–962, 1986
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